TECH BUYER Dec 2022 - IDC MarketScape - Doc # US48061622

IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment

By:

Nimita Limaye
Loading
Table of Contents

IDC MarketScape Figure

Figure: IDC MarketScape Worldwide Life Science R&D Pharmacovigilance Solutions Vendor Assessment

IDC Opinion

IDC MarketScape Vendor Inclusion Criteria

Advice for Technology Buyers

Vendor Summary Profiles

Accenture

Strengths

Challenges

Consider Accenture When

ArisGlobal

Strengths

Challenges

Consider ArisGlobal When

Cognizant

Strengths

Challenges

Consider Cognizant When

Indegene

Strengths

Challenges

Consider Indegene When

IQVIA

Strengths

Challenges

Consider IQVIA When

Navitas Life Sciences

Strengths

Challenges

Consider Navitas Life Sciences When

Oracle

Strengths

Challenges

Consider Oracle When

PwC

Strengths

Challenges

Consider PwC When

Sarjen Systems

Strengths

Challenges

Consider Sarjen Systems When

TCS

Strengths

Challenges

Consider TCS When

Veeva

Strengths

Challenges

Consider Veeva When

Vendors to Watch

Appendix

Reading an IDC MarketScape Graph

IDC MarketScape Methodology

Market Definition

Market Overview

Strategies and Capabilities Criteria

Table: Key Strategy Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions

Table: Key Capability Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions

Learn More

Related Research

Synopsis

Content


Related Links